X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-24 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.03 | -600 | 525,097 | 0% | -$12,018 | ||||||
2023-11-24 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.02 | -800 | 229,204 | 0% | -$16,016 | ||||||
2023-11-27 | RDNT | Radnet, Inc. | Gordon Christine Nayoma | Dir | S - Sale | $32.40 | -3,000 | 10,385 | -22% | -$97,200 | ||||||
2023-11-21 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $54.31 | -1,000 | 20,646 | -5% | -$54,314 | ||||||
2023-11-20 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $55.00 | -2,566 | 217,554 | -1% | -$141,130 | ||||||
| M | 2023-11-20 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.04 | -6,055 | 230,004 | -3% | -$121,330 | |||||
| M | 2023-11-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.03 | -5,610 | 525,697 | -1% | -$112,377 | |||||
2023-11-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | GC | S - Sale | $1.04 | -1,722 | 78,396 | -2% | -$1,791 | ||||||
2023-11-16 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $27.25 | -1,617 | 607,719 | 0% | -$44,065 | ||||||
2023-11-16 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $1.04 | -1,344 | 191,984 | -1% | -$1,398 | ||||||
2023-11-16 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $1.04 | -940 | 124,104 | -1% | -$978 | ||||||
2023-11-16 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $27.25 | -1,307 | 201,897 | -1% | -$35,617 | ||||||
2023-11-16 | LH | Laboratory Corp of America Holdings | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $210.71 | -1,384 | 2,087 | -40% | -$291,627 | ||||||
| DM | 2023-11-09 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.25 | -215 | 6,251 | -3% | -$268 | |||||
| DM | 2023-11-09 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.25 | -435 | 104,501 | 0% | -$543 | |||||
| DM | 2023-11-09 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.25 | -469 | 47,712 | -1% | -$585 | |||||
| DM | 2023-11-09 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.25 | -3,765 | 329,428 | -1% | -$4,699 | |||||
| DM | 2023-11-09 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.25 | -982 | 136,573 | -1% | -$1,226 | |||||
2023-11-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $40.25 | -6,000 | 524,053 | -1% | -$241,501 | ||||||
2023-11-01 | PSNL | Personalis, Inc. | Hall Christopher M | Pres, CEO | S - Sale | $0.93 | -20,459 | 204,541 | -9% | -$19,027 | ||||||
| D | 2023-10-25 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $10.23 | -350 | 8,781 | -4% | -$3,581 | |||||
| D | 2023-10-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $40.40 | -3,940 | 64,810 | -6% | -$159,195 | |||||
| D | 2023-10-23 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $40.39 | -2,595 | 220,120 | -1% | -$104,813 | |||||
| D | 2023-10-23 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $40.08 | -1,335 | 530,053 | 0% | -$53,501 | |||||
| D | 2023-10-23 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $40.39 | -803 | 179,807 | 0% | -$32,433 | |||||
2023-10-17 | XGN | Exagen Inc. | Aballi John | Pres, CEO | S - Sale | $1.75 | -33,819 | 415,984 | -8% | -$59,018 | ||||||
| D | 2023-10-12 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale+OE | $66.49 | -13,007 | 38,178 | -25% | -$864,835 | |||||
2023-10-02 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $6.91 | -2,818 | 479,164 | -1% | -$19,483 | ||||||
| DM | 2023-09-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $45.91 | -2,291 | 64,833 | -3% | -$105,185 | |||||
| D | 2023-09-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $45.82 | -2,617 | 217,554 | -1% | -$119,901 | |||||
| D | 2023-09-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $45.82 | -732 | 179,110 | 0% | -$33,537 | |||||
| D | 2023-09-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $46.06 | -5,448 | 531,055 | -1% | -$250,909 | |||||
2023-09-12 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $32.59 | -2,125 | 7,813 | -21% | -$69,254 | ||||||
| M | 2023-09-08 | DMTK | Dermtech, Inc. | Sun Kevin M | CFO | S - Sale | $1.93 | -9,616 | 282,925 | -3% | -$18,541 | |||||
| M | 2023-09-08 | DMTK | Dermtech, Inc. | Ibarra Claudia | COO | S - Sale | $1.93 | -7,700 | 200,396 | -4% | -$14,848 | |||||
2023-09-08 | DMTK | Dermtech, Inc. | Akhavan Ramin | GC | S - Sale | $1.93 | -4,531 | 142,887 | -3% | -$8,745 | ||||||
2023-09-07 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $31.41 | -1,492 | 636,838 | 0% | -$46,861 | ||||||
2023-09-07 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $31.41 | -1,492 | 214,061 | -1% | -$46,861 | ||||||
2023-09-07 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $31.41 | -1,041 | 912,932 | 0% | -$32,696 | ||||||
2023-09-06 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $59.10 | -6,000 | 536,056 | -1% | -$354,592 | ||||||
| D | 2023-09-05 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $35.01 | -100 | 4,323 | -2% | -$3,501 | |||||
2023-09-01 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.05 | -1,500 | 531,307 | 0% | -$30,078 | ||||||
2023-09-01 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.04 | -1,802 | 236,059 | -1% | -$36,112 | ||||||
2023-09-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $84.36 | -4,500 | 78,848 | -5% | -$379,620 | ||||||
2023-09-05 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $9.49 | -2,819 | 481,982 | -1% | -$26,762 | ||||||
2023-09-01 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $60.01 | -10,000 | 542,056 | -2% | -$600,062 | ||||||
| M | 2023-08-30 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.05 | -11,955 | 532,807 | -2% | -$239,708 | |||||
| M | 2023-08-30 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.04 | -11,918 | 237,861 | -5% | -$238,885 | |||||
| D | 2023-08-30 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $9.28 | -350 | 9,131 | -4% | -$3,248 | |||||
2023-08-28 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $33.62 | -10,299 | 215,553 | -5% | -$346,297 | ||||||
| D | 2023-08-23 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $9.82 | -300 | 9,481 | -3% | -$2,946 | |||||
2023-08-23 | FTRE | Fortrea Holdings Inc. | Neupert Peter M | Dir | P - Purchase | $25.30 | +11,000 | 21,996 | +100% | +$278,256 | ||||||
2023-08-23 | FTRE | Fortrea Holdings Inc. | Pike Thomas | CEO | P - Purchase | $25.23 | +20,000 | 20,000 | New | +$504,640 | ||||||
| M | 2023-08-21 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $1.69 | +128,363 | 30,707,722 | 0% | +$216,510 | |||||
2023-08-21 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale | $82.92 | -30,210 | 1,313 | -96% | -$2,505,013 | ||||||
2023-08-17 | PMD | Psychemedics Corp | Doucot Charles M | EVP | S - Sale | $4.66 | -12,700 | 23,250 | -35% | -$59,182 | ||||||
2023-08-17 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $33.88 | -1,307 | 638,330 | 0% | -$44,283 | ||||||
2023-08-17 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $33.88 | -1,798 | 225,852 | -1% | -$60,918 | ||||||
2023-08-17 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $33.88 | -342 | 913,973 | 0% | -$11,587 | ||||||
2023-08-11 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $55.00 | -2,578 | 214,988 | -1% | -$141,790 | ||||||
2023-08-14 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $8.89 | -576 | 484,801 | 0% | -$5,123 | ||||||
| DM | 2023-08-09 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.33 | -559 | 5,865 | -9% | -$742 | |||||
| DM | 2023-08-09 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.33 | -1,573 | 103,558 | -1% | -$2,088 | |||||
| DM | 2023-08-09 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.33 | -1,699 | 46,692 | -4% | -$2,256 | |||||
| DM | 2023-08-09 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.33 | -13,782 | 318,013 | -4% | -$18,297 | |||||
| DM | 2023-08-09 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.33 | -3,577 | 131,535 | -3% | -$4,749 | |||||
2023-08-08 | LH | Laboratory Corp of America Holdings | Anderson Kerrii B | Dir | S - Sale | $211.57 | -5,000 | 15,563 | -24% | -$1,057,833 | ||||||
| D | 2023-08-07 | EXAS | Exact Sciences Corp | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $85.04 | -1,350 | 9,169 | -13% | -$114,804 | |||||
2023-08-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.10 | -600 | 544,762 | 0% | -$12,060 | ||||||
2023-08-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $44.21 | -6,000 | 552,056 | -1% | -$265,265 | ||||||
2023-08-02 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $11.35 | -2,819 | 486,051 | -1% | -$31,988 | ||||||
2023-07-31 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $2.26 | -662 | 193,328 | 0% | -$1,496 | ||||||
2023-07-31 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $2.26 | -485 | 125,044 | 0% | -$1,096 | ||||||
2023-07-27 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $97.42 | -2,000 | 52,110 | -4% | -$194,840 | ||||||
2023-07-25 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $46.58 | -2,347 | 64,833 | -3% | -$109,323 | ||||||
| D | 2023-07-24 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $47.83 | -800 | 178,478 | 0% | -$38,261 | |||||
| DM | 2023-07-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $47.58 | -1,333 | 558,056 | 0% | -$63,424 | |||||
| D | 2023-07-24 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $47.83 | -1,570 | 67,180 | -2% | -$75,087 | |||||
| D | 2023-07-24 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $47.83 | -2,578 | 217,566 | -1% | -$123,296 | |||||
2023-07-19 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale | $30.17 | -3,928 | 72,774 | -5% | -$118,490 | ||||||
2023-07-19 | EXAS | Exact Sciences Corp | Herriott James | GC | S - Sale | $100.00 | -1,300 | 6,845 | -16% | -$130,000 | ||||||
| DM | 2023-07-17 | VCYT | Veracyte, Inc. | Bishop John L | Dir | S - Sale+OE | $30.25 | -20,000 | 33,125 | -38% | -$605,002 | |||||
| M | 2023-07-17 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale | $30.09 | -52,809 | 76,702 | -41% | -$1,588,918 | |||||
2023-07-13 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $10.33 | -5,260 | 488,870 | -1% | -$54,357 | ||||||
2023-07-13 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $10.34 | -5,000 | 309,657 | -2% | -$51,681 | ||||||
2023-07-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.04 | -25,116 | 545,362 | -4% | -$503,425 | ||||||
2023-07-07 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.39 | -50,000 | 249,779 | -17% | -$1,019,500 | ||||||
2023-07-03 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $8.48 | -2,818 | 498,055 | -1% | -$23,901 | ||||||
2023-06-29 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale | $240.00 | -212 | 7,605 | -3% | -$50,880 | ||||||
| DM | 2023-04-25 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $51.01 | -4,656 | 64,833 | -7% | -$237,484 | |||||
| D | 2023-06-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $50.88 | -2,605 | 214,983 | -1% | -$132,545 | |||||
| D | 2023-06-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $50.88 | -728 | 177,778 | 0% | -$37,041 | |||||
| D | 2023-06-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $50.83 | -5,447 | 559,056 | -1% | -$276,868 | |||||
2023-06-28 | CDNA | Caredx, Inc. | Seeto Reginald | See Remarks | S - Sale | $8.76 | -14,268 | 500,873 | -3% | -$125,016 | ||||||
2023-06-28 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $8.72 | -2,432 | 313,136 | -1% | -$21,216 | ||||||
| D | 2023-06-23 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $11.79 | -300 | 9,781 | -3% | -$3,537 | |||||
2023-06-16 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $26.44 | -5,893 | 28,514 | -17% | -$155,786 | ||||||
2023-06-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | GC | S - Sale | $2.07 | -1,509 | 80,118 | -2% | -$3,124 | ||||||
2023-06-16 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $2.07 | -4,817 | 125,529 | -4% | -$9,971 | ||||||
2023-06-16 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $2.07 | -6,904 | 193,990 | -3% | -$14,291 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |